BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/28/2020 3:42:19 AM | Browse: 815 | Download: 1284
 |
Received |
|
2020-01-13 08:44 |
|
Peer-Review Started |
|
2020-01-13 08:44 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-01-16 20:04 |
|
Revised |
|
2020-01-20 15:22 |
|
Second Decision |
|
2020-02-20 17:04 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-02-21 05:55 |
|
Articles in Press |
|
2020-02-21 05:55 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-02-24 02:12 |
|
Typeset the Manuscript |
|
2020-02-26 08:21 |
|
Publish the Manuscript Online |
|
2020-02-28 03:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yang Li, Fu-Hai Ma, Li-Yan Xue and Yan-Tao Tian |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81772642 |
| Capital’s Funds for Health Improvement and Research |
CFH 2018-2-4022 |
|
| Corresponding Author |
Yan-Tao Tian, MD, Professor, Surgeon, Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China. tyt67@163.com |
| Key Words |
Stomach neoplasms; Neoadjuvant therapy; Retrospective studies; Carcinoma; Signet ring cell; Outcome assessment |
| Core Tip |
Gastric cancer is the fifth most frequently diagnosed cancer and the second leading cause of cancer-related death globally. Despite a decrease in the overall incidence of gastric cancer in recent decades, the incidence of the subgroup of patients with signet-ring cell carcinoma is growing. This study provides evidence that neoadjuvant chemotherapy does not provide any survival advantage in gastric signet-ring cell carcinoma. For resectable gastric signet-ring cell carcinoma, surgery should be the primary therapy. |
| Publish Date |
2020-02-28 03:42 |
| Citation |
Li Y, Ma FH, Xue LY, Tian YT. Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study. World J Gastroenterol 2020; 26(8): 818-827 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i8/818.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i8.818 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
